Allergic manifestation 15 years after early intervention with hydrolyzed formulas - The GINI Study

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 71, Issue 2, 2016, Pages 210-219

  Von Berg, A ^a   Filipiak Pittroff, B ^a   Schulz, H ^b,c   Hoffmann, U ^b,d   Link, E ^e   Sussmann M ^b   Schnappinger, M ^b   Bruske I ^b   Standl, M ^b   Kramer U ^e   Hoffmann, B ^e   Heinrich, J ^b,c   Bauer, C P ^d,f   Koletzko, S ^g   Berdel, D ^a  

^a MARIEN HOSPITAL WESEL   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c Center for Lung Research   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f LVA Oberbayern   (Germany)

^g LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

15 year follow up from birth; allergy prevention; double blind; hydrolyzed infant formulas; nutritional intervention; randomized trial

Indexed keywords

ADOLESCENCE; ADOLESCENT; ALLERGIC RHINITIS; ALLERGY; ARTICLE; ARTIFICIAL MILK; ASTHMA; CONTROLLED STUDY; EARLY INTERVENTION; ECZEMA; EXTENSIVE CASEIN HYDROLYZATE FORMULA; EXTENSIVE WHEY HYDROLYZATE FORMULA; FOLLOW UP; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PARTIAL WHEY HYDROLYZATE FORMULA; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; ANIMAL; BOVINE; CHILD; CLINICAL TRIAL; FEMALE; HYPERSENSITIVITY; INCIDENCE; INFANT; MALE; MILK; NEWBORN; ODDS RATIO; PRESCHOOL CHILD; PREVALENCE;

MILK PROTEIN;

ADOLESCENT; ANIMALS; CATTLE; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERSENSITIVITY; INCIDENCE; INFANT; INFANT FORMULA; INFANT, NEWBORN; MALE; MILK; MILK PROTEINS; ODDS RATIO; PATIENT OUTCOME ASSESSMENT; PREVALENCE; SPIROMETRY;

EID: 84955385951     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12790     Document Type: Article

References (37)

1. American Academy of Pediatrics Committee on Nutrition. Hypoallergenic infant formulas. Pediatrics 2000; 106: 236-347.
2. Muraro A, Dreborg S, Halken S, Høst A, Niggemann B, Aalberse R, et al., Dietary prevention of allergic diseases in infants and small children. Part III: critical review of published peer-reviewed observational and interventional studies and final recommendations. Pediatr Allergy Immunol 2004; 15: 291-307.
3. Greer FR, Sicherer SH, Burks W, the Committee on Nutrition and Section on Allergy and Immunology. Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. 2008; 121: 183-191.
4. Fleischer DM, Spergel JM, Assa'ad AH, Pongracic JA,. Primary prevention of allergic disease through nutritional intervention. J Allergy Clin Immunol Pract 2013; 1: 29-36.
5. Prescott S, Tang M, Björksten B,. Primary allergy prevention in children: updated summary of a position statement of the Australasian Society of Clinical Immunology and Allergy. In:, Kemp A, Mullin R, Weiner J, editors. MJA Practice Essentials Allergy. Sydney: Australasian Medical Publishing Company; 2007: 54-58.
6. Brandt PL, Vlieg-Boerstra BJ, Dubois AE,. Dietary prevention of allergic diseases in children: are current recommendations really based on good evidence? Pediatr Allergy Immunol 2007; 18: 475-479.
7. Lowe AJ, Hosking CS, Bennett CM, Allen KJ, Axelrad C, Carlin JB, et al., Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 2011; 128: 360-365.
8. Lambers TT, Gloerich J, van Hoffen E, Alkema W, Hondmann DH, van Tol EA,. Clustering analyses in peptidomics revealed that peptide profiles of infant formulae are descriptive. Food Science nutrition 2015; 3: 81-90.
9. Allen KJ, Lowe AJ, Dharmage SC,. The role of hydrolysates for allergy prevention-con. Pediatr Allergy Immunol 2013; 24: 724-726.
10. Arshad SH,. Primary prevention of allergy by using protein hydrolysate: an achievable objective? J Allergy Clin Immunol 2013; 131: 1574-1575.
11. Hays T, Wood RA,. A systematic review of the role of hydrolyzed infant formulas on allergy prevention. Arch Pediatr Adolesc Med 2005; 159: 810-816.
12. Osborne DA, Sinn J, Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants. Cochrane Database of Syst Rev 2006; 4: CD003664.
13. Szajewska H, Horvath A,. A meta-analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases. Curr Med Res Opin 2010; 6: 423-427.
14. Alexander DD, Cabana MD,. Partially hydrolyzed 100% whey protein infant formula and reduced risk of atopic dermatitis: a meta-analysis. JPGN 2010; 50: 356-358.
15. Food and Drug administration. 100% whey-protein partially hydrolyzed infant formula and reduced risk of atopic dermatitis. 2011. Available at http://www.fda.gov/Food/LabelingNutrition/LabelClaims/QualifiedHealthClaims/ucm256731.htm.
16. Vandenplas Y, Hauser B, Van den Borre C, Clybouw C, Mahler T, Hachimi-Idrissi S, et al., The long-term effect of a partial whey hydrolyzate formula on the prophylaxis for atopic disease. Eur J Pediatr 1995; 154: 488-494.
17. Oldaeus G, Anjou K, Bjørksten B, Moran JR, Kjellman NI,. Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Arch Dis Child 1997; 77: 4-10.
18. Halken S, Hansen KS, Jacobsen HP, Estmann A, Faelling AE, Hansen LG, et al., Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatr Allergy Immunol 2000; 11: 149-161.
19. Zeiger RS,. Food allergen avoidance in the prevention of food allergy in infants and children. Pediatrics 2003; 111: 1662-1671.
20. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al., Revised nomenclature for allergy for global use: report of the nomenclature review committee of the world allergy organization, October 2003. J Allergy Clin Immunol 2004; 113: 832-836.
21. von Berg A, Filipiak-Pittroff B, Krämer U, Hoffmann B, Link E, Beckmann C, et al., Allergies in high- risk schoolchildren after early intervention with cow′s milk protein hydrolysates: 10-year results from the German Infant Nutritional intervention (GINI) study. J Allergy Clin Immunol 2013; 131: 1565-1573.
22. Chan-Yeung M, Ferguson A, Watson W, Dimich-Ward H, Rousseau R, Lilley M, et al., The Canadian childhood asthma primary prevention study: outcomes at 7 years of age. J Allergy Clin Immunol 2005; 116: 49-55.
23. Arshad SH, Bateman B, Sadeghnejad A, Gant C, Matthews SM,. Prevention of allergic diseases during childhood by allergen avoidance: the Isle of Wight prevention study. J Allergy Clin Immunol 2007; 119: 307-313.
24. Scott M, Roberts G, Kurukulaaratchy RJ, Matthews S, Nove A, Arshad SH,. Multifaceted allergen avoidance during infancy reduces asthma during childhood with the effect persisting until age 18 years. Thorax 2012; 67: 1046-1051.
25. von Berg A, Koletzko S, Grübl A, Filipiak-Pittroff B, Wichmann HE, Bauer CP, et al., The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double-blind trial. J Allergy Clin Immunol 2003; 111: 533-540.
26. von Berg A, Koletzko S, Filipiak-Pittroff B, Laubereau B, Grübl A, Wichmann HE, et al., Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three-year results of the German Infant Nutritional Intervention Study. J Allergy Clin Immunol 2007; 119: 718-725.
27. von Berg A, Filipiak-Pittroff B, Krämer U, Link E, Bollrath C, Brockow I, et al., Preventive effect of hydrolyzed infant formulas persists until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI). J Allergy Clin Immunol 2008; 121: 1442-1447.
28. Berg Av, Krämer U, Link E, Bollrath C, Heinrich J, Brockow I, et al., Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course-the GINIplus study up to the age of 6 years. Clin Exp Allergy 2010; 40: 627-36.
29. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al., Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
30. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al., Multi-ethnic reference values for spirometry for the 3-95-year age range: the global lung function 2012 equations. Eur Respir J 2012; 40: 1324-1343.
31. Schoetzau A, Gehring U, Franke K, Grübl A, Koletzko S, von Berg A, et al., Maternal compliance with nutritional recommendations in an allergy preventive programme. Arch Dis Child 2002; 86: 180-184.
32. Kleinbaum DG, Kupper LL, Morgenstern H,. Epidemiologic Research. Principles and quantitative methods. Belmont Lifetime learning publications, 1982.
33. Diggle P, Haegerty P, Liang K, Zeger S,. Analysis of Longitudinal Data. Oxford University Press, 2nd edition, 2002.
34. Mertens J, Stock S, Lüngen M, von Berg A, Krämer U, Filipiak-Pittroff B, et al., Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany. Pediatr Allergy Immunol 2012; 23: 597-604.
35. Van der Wiel E, ten Hacken NH, Postma DS, van den Berge M,. Small-airways dysfunction associates with respiratory symptoms and clinical features of asthma: a systematic review. J Allergy Clin Immunol 2013; 131: 646-657.
36. Pabst O, Mowat AM,. Oral tolerance to food protein. Muscosal Immunol 2012; 5: 232-239.
37. Koletzko S, Filipiak-Pittroff B, Koletzko B, von Berg A, Krämer U, Berdel D, et al., No reason to change the current guidelines on allergy prevention. J Allergy Clin Immunol 2012; 129: 262.